Kyverna Therapeutics, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the KYTX Class Action Lawsuit Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTK) Provided Investors with Misleading Information in Connection with its IPO